Company profile: M2P Labs
1.1 - Company Overview
Company description
- Provider of microbioreactor and biochemical engineering solutions, including the BioLector high-throughput microbioreactor for microliter-scale fermentation with online monitoring (biomass, pH, dissolved oxygen, fluorescence); the RoboLector automated cultivation platform with liquid handling; and the FlowerPlate microtiter plate for enhanced oxygen transfer, plus technical/application support, demos, installation, and maintenance contracts.
Products and services
- BioLector: A microliter-scale microbioreactor system enabling high-throughput fermentation with online monitoring of biomass, pH, dissolved oxygen, and fluorescence
- FlowerPlate: An oxygen-transfer-enhanced microtiter plate featuring flower-shaped wells engineered to increase oxygen transfer rates, suitable for microbial cell cultivation
- RoboLector: A fully automated cultivation platform integrating the BioLector microbioreactor with a liquid handling system for fully automated fermentation processes, including sampling and dosing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to M2P Labs
Esperite
HQ: The Netherlands
Website
- Description: Provider of healthcare services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Esperite company profile →
Dadi
HQ: United States
Website
- Description: Provider of at-home sperm collection kits, male fertility reports, and sperm storage, offering a clinic-free option directly to men: $99 for the kit and fertility report, then $99 per year for storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dadi company profile →
Eleva Biologics
HQ: Germany
Website
- Description: Provider of novel biological therapies developed with pharmaceutical partners, leveraging a unique moss-based production platform to produce biologics such as antibodies, replacement enzymes, and fusion toxins; has advanced drug candidates into clinical phases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eleva Biologics company profile →
ARTMS
HQ: Canada
Website
- Description: Provider of cyclotron-based technology for decentralized, local production of diagnostic imaging isotopes and purified radiopharmaceuticals. Offers the QUANTM Irradiation System (QIS) and QUANTM platforms for gallium-68, technetium-99m, zirconium-89, and copper-64, featuring automatic 2-way pneumatic transfer, a compact solid target station, and complete solid target processing solutions for PET and other clinical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ARTMS company profile →
Mesa Labs
HQ: United States
Website
- Description: Provider of biological and chemical indicators; sterilization and disinfection monitoring solutions; validation accessories; incubators; and culture media to ensure compliance and validation of sterilization and disinfection processes, and high-quality measurement instruments and accessories that it acquires, develops, manufactures, and markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mesa Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for M2P Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to M2P Labs
2.2 - Growth funds investing in similar companies to M2P Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for M2P Labs
4.2 - Public trading comparable groups for M2P Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →